S Harvey

Summary

Affiliation: National Institute for Communicable Diseases
Country: South Africa

Publications

  1. pmc Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008
    Nelesh P Govender
    Mycology Reference Unit, National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Antimicrob Agents Chemother 55:2606-11. 2011

Collaborators

  • Nelesh P Govender
  • A Von Gottberg
  • P Moodley
  • A Whitelaw
  • L Dini
  • C Heney
  • A Hoosen
  • M Dove
  • A Brink
  • M Senekal
  • S Sithole
  • Marelize Van Wyk
  • S Schrag
  • H Dawood
  • P Bhola
  • A Moller
  • L Liebowitz
  • Tom M Chiller
  • J Smit
  • O Perovic
  • Shawn R Lockhart
  • C Mutanda
  • J Frean
  • T Vanmali
  • A Sooka
  • S Martin
  • E Wasserman
  • K Bauer
  • K Ahmed
  • K Keddy
  • J Ramalivhana
  • R Lekalakala
  • L de Gouveia
  • S Budavari
  • P P Sein
  • J Wadula
  • P Jooste
  • W Sturm
  • R Hoffmann
  • X Poswa
  • A M Pretorius
  • C Feldman
  • K M McCarthy
  • S T Meiring
  • M Botha
  • J Patel
  • L Meyer
  • K P Klugman
  • Jaymati Patel
  • E G Prentice
  • J Lebudi
  • S Vasaikar
  • V C Quan
  • C Cohen
  • A Rampe
  • K Lindeque
  • G Weldhagen
  • P Smith
  • G Hoyland
  • K Hamese
  • N Janse van Rensberg
  • I Zietsman
  • A S Karstaedt
  • S Gould
  • N P Govender
  • A Schuchat
  • M da Silva
  • D Cilliers

Detail Information

Publications1

  1. pmc Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008
    Nelesh P Govender
    Mycology Reference Unit, National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, South Africa
    Antimicrob Agents Chemother 55:2606-11. 2011
    ..Although routine antifungal susceptibility testing of incident isolates is not currently recommended in clinical settings, it is still clearly important for public health to periodically monitor for the emergence of resistance...